CHM chimeric therapeutics limited

Ann: ADVENT-AML Phase 1B clinical trial update, page-22

  1. 4,386 Posts.
    lightbulb Created with Sketch. 4553
    Has anyone benchmarked this against existing venetoclax data*?

    https://hotcopper.com.au/data/attachments/7002/7002381-aec0ba16bbfd183b7123ca4f56cefc77.jpg

    https://hotcopper.com.au/data/attachments/7002/7002383-e7e7dfb9518ee3c7295521799139b1a3.jpg

    *I haven't, just a quick goooog.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.